Tracers / [18F]fluoroacetate

[18F]fluoroacetate

Also written as [18F]fluoroacetate; [F-18]fluoroacetate; Fluoroacetate
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
Syntheses indexed
2

What it is

Compound class
18F-labeled carboxylic acid (fluorinated short-chain fatty acid analog)
Target / mechanism
Aconitase (TCA cycle enzyme) / fatty acid and glial oxidative metabolism PMID 30054282
Clinical application
Liver tumors (hepatocellular carcinoma and metastatic tumors) PMID 24599824
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
55% ± 5%>99%17332620
2007 J Nucl Med
50.2 ± 4.8%
yes
>99%16459271
2006 Nucl Med Biol
a commercial [(18)F]FDG synthesizer, the TRACERlab MX(FDG) — 50.2 +/- 4.8%, decay corrected

Need this precursor?We can point you to suppliers for [18F]fluoroacetate, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); receptor ligand with a saturable target -> molar activity (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]fluoroacetate.

Get in touch

Notes

Added from reverse module search (stage 6); 2 article(s) with F-18. | Stage 28: added indication(s) neu-cerebrovascular from consolidated missing-rubric review.